Cannabis Report
Home > Boards > US Listed > Medical - Drugs >

MeiraGTx Holdings (MGTX)

MGTX RSS Feed
Add MGTX Price Alert      Hide Sticky   Hide Intro
Moderator: mcp4
Search This Board: 
Last Post: 9/10/2018 9:07:16 AM - Followers: 1 - Board type: Free - Posts Today: 0

MeiraGTx is gene therapy company focused on clinical programs for treating ocular indications, a salivary gland condition, and diseases of the central nervous system.  It has facilities in New York City, London, and the Netherlands.
Cannabis Report
MGTX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MGTX News: MeiraGTx Announces AAV-CNGA3 Granted Rare Pediatric Disease Designation by the U.S. FDA for the Treatment of Achromatopsia 08/27/2018 08:00:00 AM
MGTX News: MeiraGTx Announces AAV-CNGB3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia 08/20/2018 08:00:00 AM
MGTX News: MeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designation from the U.S. FDA for the Treatment of Achromatopsia 08/13/2018 07:00:00 AM
MGTX News: Quarterly Report (10-q) 08/08/2018 04:27:39 PM
MGTX News: Current Report Filing (8-k) 08/08/2018 08:24:24 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!